Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive assessment on the applications of oncolytic viruses for cancer immunotherapy
Richard Kolade Omole, Oluwaseyi Oluwatola, Millicent Tambari Akere, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10

Showing 10 citing articles:

New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy
Hanna Chowaniec, Antonina Ślubowska, Magdalena Mroczek, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Medication Adherence in Cancer Patients: A Comprehensive Review
V. Reshma, Arun Mathew Chacko, Naseeha Haleema Abdulla, et al.
Cureus (2024)
Open Access | Times Cited: 7
Epigenetic modulation by oncolytic viruses: Implications for cancer therapeutic efficacy
Muhammad Haris Sultan, Qi Zhang, Hao Jin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189270-189270
Closed Access
Clinical trials on oncolytic viruses
I.V. Golovinov, А. С. Гончарова, A. A. Shulga, et al.
Bulletin of Siberian Medicine (2025) Vol. 23, Iss. 4, pp. 158-168
Open Access
Cancer therapy with the viral and bacterial pathogens: The past enemies can be considered the present allies
Niloofar Kiaheyrati, Abouzar Babaei, Reza Ranji, et al.
Life Sciences (2024) Vol. 349, pp. 122734-122734
Closed Access | Times Cited: 4
On the dynamics and optimal control of a mathematical model of neuroblastoma and its treatment: Insights from a mathematical model
José García Otero, Mariusz Bodzioch, Juan Belmonte-Beitia
Mathematical Models and Methods in Applied Sciences (2024) Vol. 34, Iss. 07, pp. 1235-1278
Closed Access | Times Cited: 3
Immunogenic cell death-based oncolytic virus therapy: a sharp sword of tumor immunotherapy
Jingyu Zhang, Jiahe Chen, Kezhi Lin
European Journal of Pharmacology (2024) Vol. 981, pp. 176913-176913
Open Access | Times Cited: 3
Immunotherapy: A new target for cancer cure (Review)
Fuqian Zhao, Dao-fu Shen, Mingquan Shang, et al.
Oncology Reports (2023) Vol. 49, Iss. 5
Open Access | Times Cited: 8
Enhancing antitumor efficacy of oncolytic virus M1 via albendazole-sustained CD8+ T cell activation
Wenjing Bai, Xia Tang, Tong Xiao, et al.
Deleted Journal (2024) Vol. 32, Iss. 2, pp. 200813-200813
Open Access | Times Cited: 1
Engineering approaches for innate immune-mediated tumor microenvironment remodeling
Griffin Kane, Christina F. Lusi, Meghan L. Brassil, et al.
Immuno-Oncology Technology (2023) Vol. 21, pp. 100406-100406
Open Access | Times Cited: 4
Page 1

Scroll to top